Distal versus conventional radial access for coronary angiography and intervention: Design and rationale of DISCO RADIAL study.


Journal

American heart journal
ISSN: 1097-6744
Titre abrégé: Am Heart J
Pays: United States
ID NLM: 0370465

Informations de publication

Date de publication:
02 2022
Historique:
received: 30 07 2021
accepted: 02 10 2021
pubmed: 20 10 2021
medline: 8 4 2022
entrez: 19 10 2021
Statut: ppublish

Résumé

Transradial access (TRA) has become the default access method for coronary diagnostic and interventional procedures. As compared to transfemoral access, TRA has been shown to be safer, cost-effective and more patient-friendly. Radial artery occlusion (RAO) represents the most frequent complication of TRA, and precludes future coronary procedures through the radial artery, the use of the radial artery as a conduit for coronary artery bypass grafting or as arteriovenous fistula for patients on hemodialysis. Recently, distal radial access (DRA) has emerged as a promising alternative to TRA, yielding potential for minimizing the risk of RAO. However, an international multicenter randomized comparison between DRA, and conventional TRA with respect to the rate of RAO is still lacking. DISCO RADIAL is a prospective, multicenter, open-label, randomized, controlled, superiority trial. A total of 1300 eligible patients will be randomly allocated to undergo coronary angiography and/or percutaneous coronary intervention (PCI) through DRA or TRA using the 6 Fr Glidesheath Slender sheath introducer. Extended experience with both TRA and DRA is required for operators' eligibility and optimal evidence-based best practice to reduce RAO systematically implemented by protocol. The primary endpoint is the incidence of forearm RAO assessed by vascular ultrasound at discharge. Several important secondary endpoints will also be assessed, including access-site cross-over, hemostasis time, and access-site related complications. The DISCO RADIAL trial will provide the first large-scale multicenter randomized evidence comparing DRA to TRA in patients scheduled for coronary angiography or PCI with respect to the incidence of RAO at discharge.

Sections du résumé

BACKGROUND
Transradial access (TRA) has become the default access method for coronary diagnostic and interventional procedures. As compared to transfemoral access, TRA has been shown to be safer, cost-effective and more patient-friendly. Radial artery occlusion (RAO) represents the most frequent complication of TRA, and precludes future coronary procedures through the radial artery, the use of the radial artery as a conduit for coronary artery bypass grafting or as arteriovenous fistula for patients on hemodialysis. Recently, distal radial access (DRA) has emerged as a promising alternative to TRA, yielding potential for minimizing the risk of RAO. However, an international multicenter randomized comparison between DRA, and conventional TRA with respect to the rate of RAO is still lacking.
TRIAL DESIGN
DISCO RADIAL is a prospective, multicenter, open-label, randomized, controlled, superiority trial. A total of 1300 eligible patients will be randomly allocated to undergo coronary angiography and/or percutaneous coronary intervention (PCI) through DRA or TRA using the 6 Fr Glidesheath Slender sheath introducer. Extended experience with both TRA and DRA is required for operators' eligibility and optimal evidence-based best practice to reduce RAO systematically implemented by protocol. The primary endpoint is the incidence of forearm RAO assessed by vascular ultrasound at discharge. Several important secondary endpoints will also be assessed, including access-site cross-over, hemostasis time, and access-site related complications.
SUMMARY
The DISCO RADIAL trial will provide the first large-scale multicenter randomized evidence comparing DRA to TRA in patients scheduled for coronary angiography or PCI with respect to the incidence of RAO at discharge.

Identifiants

pubmed: 34666014
pii: S0002-8703(21)00432-4
doi: 10.1016/j.ahj.2021.10.180
pii:
doi:

Types de publication

Journal Article Multicenter Study Randomized Controlled Trial Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

19-30

Informations de copyright

Copyright © 2021. Published by Elsevier Inc.

Auteurs

Adel Aminian (A)

Department of Cardiology, Centre Hospitalier Universitaire de Charleroi, Charleroi, Belgium. Electronic address: adaminian@hotmail.com.

Gregory A Sgueglia (GA)

Division of Cardiology, Sant'Eugenio Hospital, Rome, Italy.

Marcus Wiemer (M)

Department of Cardiology and Intensive Care, Johannes Wesling University Hospital Ruhr University Bochum, Minden, Germany.

Gabriele Luigi Gasparini (GL)

Humanitas Clinical and Research Center, IRCCS, Rozzano-Milan, Italy.

Joelle Kefer (J)

Division of Cardiology, Cliniques Universitaires Saint-Luc, Brussels, Belgium.

Zoltan Ruzsa (Z)

Department of Internal Medicine, Invasive Cardiology Division, University of Szeged, Medical Faculty, Szeged, Hungary; Cardiology Division, Bács-Kiskun County Hospital, Invasive Cardiology, Kecskemét, Hungary.

Maarten A H van Leeuwen (MAH)

Department of Cardiology, Isala Heart Center, Zwolle, the Netherlands.

Bert Vandeloo (B)

Department of Cardiology, Universitair Ziekenhuis Brussel, Vrije Universiteit Brussel (VUB), Brussels, Belgium.

Claudiu Ungureanu (C)

Department of Cardiology, Jolimont Hospital, La Louvière, Belgium.

Sasko Kedev (S)

Interventional Cardiology Department, University Clinic of Cardiology, Skopje, Macedonia.

Juan F Iglesias (JF)

Department of Cardiology, Geneva University Hospital, Geneva, Switzerland.

Gregor Leibundgut (G)

Kantonsspital Baselland, Liestal, Switzerland.

Karim Ratib (K)

Centre for Prognosis Research, Keele Cardiovascular Research Group, Institute for Primary Care and Health Sciences, Keele University, United Kingdom.

Ivo Bernat (I)

Department of Cardiology, University Hospital and Faculty of Medicine Pilsen, Charles University, Pilsen, Czech Republic.

Irene Barriocanal (I)

European Medical and Clinical Division, Terumo Europe N.V., Leuven, Belgium.

Vladimir Borovicanin (V)

European Medical and Clinical Division, Terumo Europe N.V., Leuven, Belgium.

Shigeru Saito (S)

Department of Cardiology, Shonan Kamakura General Hospital, Kanagawa, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH